 Oak Ridge, TN, Sept. 01, 2021 GLOBE NEWSWIRE -- Daxor Corporation NYSE: DXR, the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on form N-CSR on August 30, 2021, from CEO President, Michael Feldschuh: 